BIDANG FARMASI
NUKLIR DALAM
DUNIA FARMASI
In designing a radiopharmaceutical, a
pharmaceutical is first chosen on the basis of its
preferential localization in a given organ or its
participation in the physiologic function of the
organ.
Then a suitable radionuclide is tagged onto the chosen
pharmaceutical such that after administration of the
radiopharmaceutical, radiations emitted from it are detected
by a radiation detector.
Easy availability
Short effective Half-Life
Minimal Particle Emission
Decay by Electron Capture or Isomeric Transition
High Target-to Non target Activity Ratio
1. Easy Availability
The geographic distance between the user and the supplier also
limits the availability of short-lived radiopharmaceuticals.
2. Short Effective Half-Life
e = p + b
Since = 0.693/t1/2, it follows that
1/Te = 1/Tp + 1/Tb
OR
Te = ( Tp X Tb) / ( Tp + Tb )
Problem 6.1
The physical half-life of 111In is 67 hr and the biologic half-life of
111In-DTPA used for measurement of the glomerular filtration rate is
1.5 hr. What is the effective half-life of 111In-DTPA?
3. Particle Emission
Inpatient
Diagnosis Therapy
Radiopharmaceuticals
Radionuclides
Generators Cyclotron
Nuclear Reactor
Cara Mendapatkan Sediaan Radiofarmaka
L R
B. Uji Fungsi Kelenjar Gondok ( Thyroid Uptake )
Pasien diberi 131I untuk diminum dan 2 jam setelah itu pasien
menjalani pemeriksaan.
26
Gamma Camera Examination
27
Gamma Camera Examination
28
Tabel : Sediaan radiofarmaka dan pemakaiannya